Compare KSS & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KSS | BLFS |
|---|---|---|
| Founded | 1962 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 1.2B |
| IPO Year | 1992 | 1989 |
| Metric | KSS | BLFS |
|---|---|---|
| Price | $23.02 | $25.40 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 13 | 4 |
| Target Price | $15.55 | ★ $31.50 |
| AVG Volume (30 Days) | ★ 7.1M | 360.9K |
| Earning Date | 11-25-2025 | 11-06-2025 |
| Dividend Yield | ★ 2.16% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.73 | N/A |
| Revenue | ★ $15,751,000,000.00 | $100,144,000.00 |
| Revenue This Year | N/A | $20.67 |
| Revenue Next Year | N/A | $14.13 |
| P/E Ratio | $13.41 | ★ N/A |
| Revenue Growth | N/A | ★ 87.53 |
| 52 Week Low | $6.04 | $19.10 |
| 52 Week High | $25.22 | $29.62 |
| Indicator | KSS | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 60.58 | 48.48 |
| Support Level | $21.84 | $24.11 |
| Resistance Level | $23.41 | $25.98 |
| Average True Range (ATR) | 1.16 | 0.82 |
| MACD | -0.23 | 0.05 |
| Stochastic Oscillator | 45.90 | 62.41 |
Kohl's operates about 1,150 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also has a large digital sales operation. Women's apparel is Kohl's largest category, having generated 25% of its 2024 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.